DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,879 INR | -2.93% |
|
-5.25% | +1.40% |
| May. 09 | Asian Equities Traded in the US as American Depositary Receipts Trend Lower Thursday | MT |
| May. 09 | India's Alembic Pharma posts higher Q4 profit on strong N.America sales | RE |
Presenter SpeechAmit Agarwal (Executives)So greetings to all of you. And thank you for being h...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-07-23
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
5,879
INR
Average target price
6,086
INR
Spread / Average Target
+3.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.40% | 12.08B | |
| +32.36% | 698B | |
| +26.51% | 568B | |
| -4.40% | 358B | |
| +19.46% | 328B | |
| +3.50% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.62% | 165B |
- Stock Market
- Equities
- DRREDDY Stock
- News Dr. Reddy's Laboratories Limited
- Transcript : Dr. Reddy's Laboratories Limited - Analyst/Investor Day